NCT01956487View on ClinicalTrials.gov

Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites

PHASE1CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

April 11, 2012

Primary Completion Date

June 27, 2012

Study Completion Date

June 27, 2012

Conditions

Arrhythmia, Cardiac

Interventions

DRUG

Propafenone

Comparison of drug from 2 manufacturing sites

Trial Locations (1)

21225

GSK Investigational Site, Baltimore

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY